Corcept Therapeutics Total Interest Expense (Quarterly):1.166M for Sept. 30, 2013
View 4,000+ financial data types
Corcept Therapeutics Total Interest Expense (Quarterly) Chart
Corcept Therapeutics Historical Total Interest Expense (Quarterly) DataPro Export Data Date Range:
|Data for this Date Range|
|Sept. 30, 2013||1.166M|
|June 30, 2013||1.114M|
|March 31, 2013||1.141M|
|Dec. 31, 2012||1.144M|
|Sept. 30, 2012||0.622M|
|June 30, 2012||0.005M|
|March 31, 2012||0.005M|
|Dec. 31, 2011||0.008M|
|Sept. 30, 2011||0.001M|
There is no data for the selected date range.
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
CORT Total Interest Expense (Quarterly) Benchmarks
CORT Total Interest Expense (Quarterly) Range, Past 5 Years
Seeking Alpha Nov 9
Reuters Nov 7